(Q105004813)

http://api.crossref.org/works/10.1016%2Fs0040-4020%2898%2983004-4

1 reference

1 reference

N-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycine

1 reference

1 reference

1 reference

Takayuki Nemoto

1

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2898%2983004-4

Makoto Ojika

2

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2898%2983004-4

Yoshinori Takahata

3

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2898%2983004-4

Toshiwo Andoh

4

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2898%2983004-4

Youji Sakagami

5

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2898%2983004-4

publication date

March 1998

1 reference

16 September 2022

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2898%2983004-4

volume

54

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2898%2983004-4

issue

12

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2898%2983004-4

page(s)

2683-2690

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2898%2983004-4

cites work

Topostin, a novel inhibitor of mammalian DNA topoisomerase I from Flexibacter topostinus sp. nov. II. Purification and some properties of topostin

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2898%2983004-4

7 January 2021

Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2898%2983004-4

7 January 2021

Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2898%2983004-4

7 January 2021

Phospholipids and a novel glycine-containing lipoamino acid in Cytophaga johnsonae Stanier strain C21.

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2898%2983004-4

7 January 2021

Studies on WB-3559 A, B, C and D, new potent fibrinolytic agents. II. Structure elucidation and synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2898%2983004-4

7 January 2021

Studies on WB-3559 A,B,C and D, new potent fibrinolytic agents. I. Discovery, identification, isolation and characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2898%2983004-4

7 January 2021

Acidic phospholipids directly inhibit DNA binding of mammalian DNA topoisomerase I.

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2898%2983004-4

7 January 2021

Inhibition of Escherichia coli DNA topoisomerase I activity by phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2898%2983004-4

7 January 2021

Amphimic acids, novel unsaturated C28 fatty acids as DNA topoisomerase I inhibitors from an Australian sponge Amphimedon sp.

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2898%2983004-4

7 January 2021

Novel ceramide 1-sulfates, potent DNA topoisomerase I inhibitors isolated from the Bryozoa Watersipora cucullata

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2898%2983004-4

7 January 2021

Mechanism of inhibition of mammalian DNA topoisomerase I by heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2898%2983004-4

7 January 2021